Optical imaging for monitoring tumor oxygenation response after initiation of single-agent bevacizumab followed by cytotoxic chemotherapy in breast cancer patients.

Optical imaging for monitoring tumor oxygenation response after initiation of single-agent bevacizumab followed by cytotoxic chemotherapy in breast cancer patients.

PURPOSE: Optical imaging techniques for measuring tissue hemoglobin concentration have been recently accepted as a way to assess tumor vascularity and oxygenation. We investigated the correlation between early optical response to single-agent bevacizumab and treatment outcome. METHODS: Seven patient...

Full description

Bibliographic Details
Main Authors: Shigeto Ueda, Ichiei Kuji, Takashi Shigekawa, Hideki Takeuchi, Hiroshi Sano, Eiko Hirokawa, Hiroko Shimada, Hiroaki Suzuki, Motoki Oda, Akihiko Osaki, Toshiaki Saeki
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4048242?pdf=render

Similar Items

Similar Items